Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
iNtRON confirms cancer-controlling effect of PHAGERIA® drug candidate in the organoid model. 2023-04-04 10:33
RVAC Medicines announces research collaboration with University of Pennsylvania mRNA Vaccine Pioneer 2023-03-17 21:00
Assure Tech Launches a New Platform - Comprehensive Health Solution 2023-03-06 18:47
The first case of COVID pregnant mother in Guangzhou was successfully delivered by cesarean section and the newborn was in good condition; doctors treat pregnant COVID-19 patient Under Quarantine Protection 2023-02-27 17:18
Huichao Liang, An Expert on AIDS Combined with Gynecological Oncology, Receives Excellent Popular Science Worker Award 2023-02-24 16:37
GC Biopharma Receives WHO Pre-Qualification for BARYCELA 2023-02-20 09:38
Global Times: Small and mid-sized cities in China go through infection peak, bearing new hope for future 2023-02-01 22:45
Global Times: Having weathered epidemic storms overseas, Chinese return to hometown for safe, joyous Spring Festival reunions 2023-01-31 22:10
Global Times: 'So much better than we had anticipated': China's rural regions embrace Spring Festival as COVID peak ebbs away 2023-01-31 21:41
SK bioscience Introduces New Partnership Model to Establish Regional Vaccine Hubs 2023-01-27 20:00
Looking Back on Three Years of COVID-19 in China 2023-01-13 22:29
Global Times: Connected in recognition: Foreign ambassadors signal a welcome for China's optimized, responsible COVID policy 2023-01-11 18:24
Global Times: 'Zhang Wenhong phenomenon' shows inclusiveness of China's public opinion sphere; policymaking based on science helps nation firmly hold strategic initiative of epidemic fight 2023-01-11 17:49
Global Times: China shifts COVID policy with necessary conditions 2023-01-05 23:21
China enters new stage in COVID-19 response 2022-12-29 22:00
Global Times: Three years' hard effort to fight COVID-19 'worthwhile' 2022-12-28 21:38
PHASE II/III CLINICAL TRIAL OF SIMCERE'S 3CL-TARGETING ANTI-SARS-COV-2 DRUG CANDIDATE COMPLETE ALL PATIENTS ENROLLMENT 2022-12-20 19:21
E-Home Household Services Holdings Limited's subsidiary Zhong Run Launches Cloud Pharmacy Service to Address New Situation of Epidemic Prevention and Control 2022-12-14 21:30
Epidemic: Modified approach ensures maximum benefit 2022-12-13 11:42
Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp 2022-12-05 20:00
1 2 3 4 5 20